IPHA Innate Pharma

USD 2.46 0.06 2.5
Icon

Innate Pharma (IPHA) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

Strong Buy

Top Analyst
Rating
stockTargetAdvisor

Slightly Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 2.46

+0.06 (+2.50)%

USD 0.23B

6.80K

USD 11.50(+367.48%)

N/A

Icon

IPHA

Innate Pharma (USD)
COMMON STOCK | NSD
USD 2.46
0.00 0
Take a Tour

Discussions

No discussions yet.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...